Introducing a hot start PCR enzyme for research use with 2-color dye and 2x premix type!
The "Hot-Start Gene RED PCR Mix" is a 2x premix type PCR reagent that has been hot-started using an antibody method, based on the conventional Gene RED PCR Mix Plus. The buffer composition has been optimized to support high-speed PCR (extension time of 10 seconds/kb). It can amplify relatively GC-rich sequences (about 69%) and long fragments (10kb). Additionally, since the dye and density adjustment agents are premixed, the reaction solution after PCR can be directly applied to an agarose gel. 【Features】 ■ Simple and speedy usage ■ Suppresses non-specific amplification through the Hot Start PCR method ■ Accommodates a wide range of experiments while ensuring sufficient amplification ■ PCR can be performed by simply adding template DNA and primers *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Product Contents (Partial)】 <Hot-Start Gene RED PCR Mix (for 48 reactions)> ■ Components: Hot-Start Gene RED PCR Mix (2X) ■ Volume: 1.2 ml x 1 ■ Storage: -20℃ *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Colony PCR ■ For routine checks such as insert confirmation ■ The obtained PCR products can be used for TA cloning *For more details, please refer to the related links or feel free to contact us.
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.
